Musculoskeletal (MSK) Disease Management Market is Forecasted to Reach CAGR of 22.8% by 2030
Global Musculoskeletal (MSK) Disease Management Market research report offers CAGR value fluctuations during the forecast period of 2023-2030 for the market. It is a fully informative and proficient report that focuses on primary and secondary market drivers, market share, leading segments and geographical analysis. A proficient team works meticulously with their potential capabilities to generate this finest market research report. The winning Global Musculoskeletal (MSK) Disease Management Market report is a specific study of the HELATH industry which explains what the market definition, classifications, applications, engagements, and global industry trends are. This report helps to stay on the right path by making to focus on the data and realities of the industry.
The rising demand for use of MSK disease management in drug development and design is expected to drive market growth in the global scenario. Data Bridge Market Research analyzes that the global musculoskeletal (MSK) disease management market will grow at a CAGR of 22.8% during the forecast period of 2023 to 2030.
Download PDF Sample Report (Including Graphs, Charts, and List of Figures) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-musculoskeletal-msk-disease-management-market&Shri
Musculoskeletal (MSK) disease or impairments comprise more than 150 different diseases or conditions, which internally affect the human system and are characterized by deficiencies in the muscles, bones, joints and adjacent connective tissues, which lead to lifelong hindrances in functioning and participation. The conditions are characterized by pain, limited gait movement and dexterity thereby, reducing people’s aptitude to work and participate in society.
The management of MSK diseases involves consultation with a physician, integrated with telemedicine, which is the use of Digital Biofeedback Systems (DBSs), MDAs and therapies. Physical activity and weight management programs are also important self-management activities for persons with arthritis. Virtual therapy or remote consultation entails a holistic approach with the implementation of video conference and phone consultations in MSK practice.
Rising number of strategic initiatives by the major players across the world will drive the market’s growth rate
Strategic initiatives by market players, product development, use of telemedicine in MSK disease management, and increased use of MDAs and home healthcare for MSK disease management may act as an opportunity for market growth. However, the challenges physicians face while treating athletes with MSK diseases and strict regulatory guidelines for MSK disease management may create challenges for market growth. There are recent developments worldwide related to the market.
Segment Analysis:
The global musculoskeletal (MSK) disease management market is segmented into seven segments based on type, technology, integration type, modality, application, patient population, and end-user.
- Based on type, the market is segmented into digital biofeedback system, musculoskeletal-focused digital apps (MDAs), solutions, and others. In 2023, the digital biofeedback system segment is expected to dominate the market with a market share of 52.55% due to better potency, improved compliance, ease of convenience. The digital biofeedback systems provide rehabilitation, provide the users with customized guidance and gives the ability to practice new ways to control the body to improve physical performance.
- Based on technology, the market is segmented into precision motion technology, computer vision technology, and other technologies. In 2023, the precision motion technology segment is expected to dominate the market with a market share of 59.45% due to the rising population with subsequent orthopaedic problems and initiatives taken by market players.
- Based on integration type, the market is segmented into phone, tablet, computers, and others. In 2023, the phone segment is expected to dominate the market with a market share of 52.95% due to better potency, improved compliance, ease of convenience, and creating an opportunity for MSK developers to meet the challenge requisites such as pain reduction and providing the users with customized guidance and exercise based on the movement, activity, and progress made by these users, which are also the factors expected to drive segment growth.
- Based on modality, the market is segmented into virtual therapy, in-person therapy, customized/personalized therapy, and others. In 2023, the virtual therapy segment is expected to dominate the market with a market share of 55.61% since virtual therapy provides better solutions such as assessment and feedback, also the sessions conducted deliver improvement in pain management, gait, physical function, rise in patient population, and improved patient outcomes, which are expected to drive segment growth.
- Based on application, the market is segmented into pre-surgery applications, post-surgery applications, and others. In 2023, the pre-surgery application segment is expected to dominate the market with a market share of 54.02% due to the rising population with subsequent orthopedic problems and initiatives taken by market players.
- Based on patient population, the market is segmented into pediatrics, adults, and geriatrics. In 2023, the pediatrics segment is expected to dominate the market with a market share of 54.55% due to rise in cases of MSK diseases such as rickets among children aged above 5 years of age, followed by subsequent orthopedic problems among pediatrics and initiatives taken by market players, which are the factors expected to drive segment growth.
The pediatrics segment will dominate the patient population segment of the musculoskeletal (MSK) disease management market
The pediatrics segment will emerge as the dominating segment under patient population. This is because of the growing number of infrastructural development activities in the market especially in the developing economies. Further, growth and expansion of the healthcare industry all around the globe will further bolster the growth of this segment.
- Based on end user, the market is segmented into hospitals & clinics, nursing homes, health centers, rehabilitation centers, virtual/home healthcare settings, and others. In 2023, the hospitals & clinics segment is expected to dominate the market with a market share of 43.48% due to better infrastructure, improved patient compliance, ease of convenience, and creating an opportunity for global musculoskeletal (MSK) disease management market developers to meet the challenge requisites such as pain reduction, and providing the users with customized guidance and treatment based on the movement, activity, and progress made by these, which are expected to drive segment growth.
To Gain More Insights into the Market Analysis, Browse Summary of the Research Report@ https://www.databridgemarketresearch.com/reports/global-musculoskeletal-msk-disease-management-market?Shri
Market Development
- In March 2021, SpineZone declared an investment of USD 12.00 million in series A funding to integrate virtual and in-person (telemedicine) MSK care. The investment made is expected to expand the product and business footprint across North America and Europe with new funds.
- In September 2021, IncludeHealth launched the MSK operating system for virtual physical therapy. The MSK operating system provides an integrated virtual and in-person care telehealth experience. The launch was a result of the collaboration of IncludeHealth with Google and ProMedica Health Systems. The launch resulted in the expansion of the product portfolio and a rise in sales.
- In May 2020, Omada Health, Inc. acquired Physera, an MSK care company that delivers muscular intervention via remote telehealth services. The acquisition allowed the addition of Physera’s MSK solutions to the product portfolio, which resulted in the expansion of the product range.
Regional Analysis
Geographically, the countries covered in the market report are U.S., Canada, Mexico in North America, Germany, Sweden, Poland, Denmark, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe in Europe, Japan, China, India, South Korea, New Zealand, Vietnam, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), Brazil, Argentina, Rest of South America as a part of South America, UAE, Saudi Arabia, Oman, Qatar, Kuwait, South Africa, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).
Browse the complete table of contents at – https://www.databridgemarketresearch.com/toc/?dbmr=global-musculoskeletal-msk-disease-management-market&Shri
Top DBMR Healthcare Reports:
Musculoskeletal Disorders Drugs Market – Industry Trends and Forecast to 2029
Europe Musculoskeletal (MSK) Disease Management Market – Industry Trends and Forecast to 2030
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Contact Us:-
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com
